periampullary adenocarcinoma (Cancer)
Information
- Disease name
- periampullary adenocarcinoma
- Disease ID
- DOID:8110
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01781728 | Active, not recruiting | Phase 2 | Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma | January 1, 2013 | December 2024 |
| NCT00983268 | Completed | Phase 1 | Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer | October 2009 | February 2013 |
| NCT00987766 | Completed | Phase 1 | Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer | November 2009 | October 2016 |
| NCT05788029 | Not yet recruiting | N/A | Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas | December 2023 | December 2025 |
| NCT02757859 | Recruiting | N/A | High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery | April 27, 2016 | January 2025 |
| NCT03724994 | Recruiting | Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer | October 30, 2018 | September 1, 2027 | |
| NCT01229111 | Terminated | Phase 2 | Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers | October 2010 | March 2014 |
| NCT00832637 | Terminated | Phase 2 | Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers | August 2007 | March 15, 2017 |
| NCT01811277 | Unknown status | Phase 2 | SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer | July 2010 | July 2014 |
- Disase is a (Disease Ontology)
- DOID:3502
- Cross Reference ID (Disease Ontology)
- NCI:C27322
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C1335377